Diagnostic Efficacy of Cerebrospinal Fluid Procalcitonin as a Novel  Biomarker in Neonatal Bacterial Meningitis: An Original Observational  Study

Dr sakalesh Hosamani, Dr Aishwarya Patil, Dr. Mahantesh Matti

Diagnostic Efficacy of Cerebrospinal Fluid Procalcitonin as a Novel Biomarker in Neonatal Bacterial Meningitis: An Original Observational Study

Authors

Dr sakalesh Hosamani, Dr Aishwarya Patil, Dr. Mahantesh Matti

Keywords:

Neonatal Meningitis; Cerebrospinal Fluid; Procalcitonin; Biomarker; Neonatal Sepsis; Diagnostic Accuracy.

Abstract

mortality and severe neurological sequelae.Because conventional cerebrospinal fluid (CSF)parameters and blood cultures often presentdiagnostic dilemmas—especially in preterm infants or following traumatic lumbarpunctures—reliable early biomarkers areurgently required.

References

1. Ku LC, Bizzarro MJ. Meningitis in neonates. Clin Perinatol. 2018;45(1):89-107.

2. Thaver D, Zaidi AK. Burden of neonatal infections in developing countries. Pediatr Infect Dis J. 2009;28(1 Suppl):S3-S9

Downloads

Published

2026-09-03

How to Cite

Dr sakalesh Hosamani, Dr Aishwarya Patil, Dr. Mahantesh Matti. (2026). Diagnostic Efficacy of Cerebrospinal Fluid Procalcitonin as a Novel Biomarker in Neonatal Bacterial Meningitis: An Original Observational Study . International Journal of Pharmacy Research & Technology (IJPRT), 16(2), 4127–4130. Retrieved from https://ijprt.org/index.php/pub/article/view/2978